Standard osteoporosis care has a timing problem: guidelines don't recommend routine screening until age 65 for women (and rarely screen men at all), and even then they rely on a single DEXA density number that only changes noticeably after years. Bone turnover markers — blood tests called CTX and P1NP — solve both problems by showing whether your bones are actively building or breaking down right now, often revealing change within weeks instead of years. For anyone serious about protecting their skeleton, this is the difference between watching in the rearview mirror and steering in real time.
Let me walk you through what these tests are, what the numbers mean, and why the traditional setting is so far behind.
What are bone turnover markers?
Your bones are living tissue in constant renewal — old bone is broken down (resorption) and new bone is laid down (formation) every day. Bone turnover markers are blood tests that measure the pace of each side of that process. A DEXA scan tells you how much bone you have; turnover markers tell you what your bone is doing. That's a crucial distinction, because activity always changes before density does.
P1NP and CTX: the two numbers that matter
The two markers that international bone experts (the IOF, ESCEO, and IFCC) have reaffirmed as the <a href="https://www.osteoporosis.foundation/news/joint-consensus-highlights-role-bone-turnover-markers-osteoporosis-diagnosis-and-management" style="color:#587692;text-decoration:underline;text-underline-offset:3px;">reference standards</a> are:
<strong>P1NP (procollagen type 1 N-terminal propeptide)</strong> — a marker of bone formation. Higher means your body is actively building bone.
<strong>CTX (C-terminal telopeptide)</strong> — a marker of bone resorption. Higher means your body is actively breaking bone down.
Together they show the balance between construction and demolition. And because they respond fast, they're powerful for monitoring: changes can be detected as early as <a href="https://academic.oup.com/edrv/article/44/3/417/6889555" style="color:#587692;text-decoration:underline;text-underline-offset:3px;">one month after starting a therapy</a>, compared with the year or two you'd wait to see a shift on DEXA.
A DEXA scan tells you how much bone you have. Turnover markers tell you which direction it's headed — and that's the number you can actually act on.
What does the P1NP:CTX ratio tell you?
Looking at the two markers together — the balance of formation (P1NP) to resorption (CTX) — gives you a picture of your net bone economy. When formation is keeping pace with or outrunning breakdown, you're in a bone-favorable, building state. When resorption dominates, you're losing ground. Tracking this balance over time is especially useful for confirming that a plan is working: that bone-building therapy is actually driving formation, that hormone optimization is calming excess resorption, or that your exercise and nutrition strategy is moving the balance in your favor. It turns bone health from a guessing game into something measurable and adjustable.
Why don't standard checkups catch bone loss earlier?
Because the standard tool — DEXA — is a slow, static snapshot. It's excellent for diagnosing established low bone density, but it can take years to register meaningful change, and it says nothing about the quality of your bone or the speed at which you're losing it. Two people with the same DEXA score can have very different trajectories: one stable, one rapidly losing. Turnover markers reveal that hidden velocity — and velocity is what lets you intervene before the damage is done.
How far behind is traditional screening?
This is the part that frustrates me most. The <a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening" style="color:#587692;text-decoration:underline;text-underline-offset:3px;">US Preventive Services Task Force</a> recommends routine osteoporosis screening for women 65 and older (and younger postmenopausal women only if they're already flagged as high risk). Men aren't routinely screened at all. The practical effect is that most people aren't evaluated until their 60s — often after bone loss is well established, and sometimes after a first fracture. But the fastest bone loss for women happens in the years around menopause, typically in the late 40s and 50s. Waiting until 65 means missing the exact window when action matters most.
Screening that starts at 65 is screening that starts a decade too late for the women losing bone fastest.
What newer diagnostics are available?
Beyond turnover markers, the toolkit has expanded well past a single density number:
<strong>Trabecular Bone Score (TBS)</strong> — an add-on analysis of your DEXA that assesses bone quality and microarchitecture, not just quantity. Two bones of equal density can differ in strength; TBS helps tell them apart.
<strong>FRAX</strong> — a validated fracture-risk calculator that combines your bone density with clinical risk factors to estimate your actual 10-year fracture risk.
<strong>REMS (Radiofrequency Echographic Multi Spectrometry)</strong> — a newer, <a href="https://link.springer.com/article/10.1007/s40520-024-02784-w" style="color:#587692;text-decoration:underline;text-underline-offset:3px;">radiation-free ultrasound technology</a> that assesses bone density at the spine and hip and also generates a "fragility score" reflecting bone quality. It's portable, involves no radiation, and is emerging as a valuable complement to DEXA.
Layered with CTX and P1NP, these turn bone assessment from a single blurry photo into a detailed, dynamic picture.
How do these change your plan?
Precisely, and quickly. Instead of scanning once and waiting years to find out whether anything worked, we can establish your baseline, start a targeted plan — exercise, nutrients, hormone optimization, or medication — and recheck your turnover markers within months to confirm the balance is shifting the right way. It's the same test-intervene-retest philosophy that defines good precision medicine, applied to a system that has been treated far too passively for far too long.
We don't wait for a milestone birthday or a broken bone to pay attention to your skeleton. Through our Advanced Labs & Genetics and Precision Wellness programs, we can assess bone turnover with CTX and P1NP, layer in the newer imaging and risk tools, and — where hormones are driving the picture — address the root cause through Women's Vitality care. If you've been told you're "too young to worry about bones," that's exactly the mindset that costs people their strength and independence later. Book a consultation and let's get ahead of it.
